Company Overview
Platform that lets individuals own and control their genomic data as blockchain-secured digital assets, sharing or revoking researcher access.
CURRENT VALUATION
$15M
Mark-to-market holdco book valueENTRY VALUATION
$1.4M
Pre-seed acceleration roundVINTAGE / COHORT
2022HOLDCO ASSET
Initial entry cohortECOSYSTEM TRACK
BioTech
Global founder cohortInvestment Thesis & Acceleration
Expert DOJO backed GenoBank during early acceleration to scale market distribution, assemble high-conviction syndicates, and expand operations into key international markets. The company exemplifies our core thesis of backing relentless operators solving urgent systemic workflows.
Uses liquid chromatography-mass spectrometry and machine learning to produce validated, submission-ready molecular testing data for biopharma.
Maker of point-of-care regenerative medicine devices (FDA-cleared MiniTC and Mini-Stem System) that process autologous fat into microfat and SVF.
Real-world data platform and patient registry for regenerative medicine and orthobiologics that turns clinical outcomes into actionable insights.